chronic imaging windows in mice have been developed to allow intravital microscopy of many different organs and have proven to be of paramount importance in advancing our knowledge of normal and disease processes. a model system that allows long-term intravital imaging of lymph nodes would facilitate the study of cell behavior in lymph nodes during the generation of immune responses in a variety of disease settings and during the formation of metastatic lesions in cancer-bearing mice. We describe a chronic lymph node window (clnW) surgical preparation that allows intravital imaging of the inguinal lymph node in mice. the clnW is custom-made from titanium and incorporates a standard coverslip. It allows stable longitudinal imaging without the need for serial surgeries while preserving lymph node blood and lymph flow. We also describe how to build and use an imaging stage specifically designed for the clnW to prevent (large) rotational changes as well as respiratory movement during imaging. the entire procedure takes approximately half an hour per mouse, and subsequently allows for longitudinal intravital imaging of the murine lymph node and surrounding structures for up to 14 d. small-animal surgery experience is required to successfully carry out the protocol.
IntroDuctIon
Our protocol describes the surgical preparation and implantation of a chronic lymph node window (CLNW) into mice 1 , as well as the design of the titanium CLNW frame, processes for using the CLNW with intravital microscopes, including multiphoton microscopy (MPM), and advice for postprocedural follow-up. The subiliac (inguinal) lymph node of the mouse, which is situated in the fold of the flank (regio inguinalis) cranial to the thigh musculature 2 , is revealed by this window preparation.
Ex vivo studies and intravital microscopy of the dynamic microenvironment of the lymph node have expanded our understanding of immune cell interactions [3] [4] [5] [6] [7] [8] . This pioneering microscopy work used acute lymph node preparations that allowed lymph node imaging over several hours. However, to study the development of lymph node metastasis and immune cell trafficking in adaptive immune responses, longitudinal imaging is needed over days and weeks. Previously, an internal lymph node window was created to study the progression of lymphoma 9 . However, this method required successive surgeries to expose the imaging window. Motivated by these seminal methods, we developed the CLNW surgical preparation 1 to facilitate imaging of lymph node anatomy, cancer cell growth and immune cell trafficking over the course of 14 d.
Applications of the method
The CLNW was designed to be used in conjunction with intravital microscopy. Intravital microscopy of secondary lymphoid organs has proven valuable in understanding immune cell function and activation 3, 7, 8 , as well as malignancy 1, 9 . Other applications may include studying or labeling of blood and lymph to understand fluid and antigen flows in the lymph node 10, 11 , as well as immune and tumor cell trafficking. To achieve the latter application, murine tumor cell lines can be administered to the mice before imaging to generate spontaneous inguinal lymph node metastasis. MPM has proven useful because of its superior tissue penetration in vivo 12, 13 as compared with other fluorescence-based techniques of similar spatial resolution. Images can be created in the CLNW from depths of several hundred microns using MPM in vivo 1 . Optical coherence tomography (OCT) [14] [15] [16] can be used for deeper imaging of the lymph node in the CLNW, although this technique currently has a lower spatial resolution.
Comparison with other models that use chronic windows
There are multiple chronic windows available for intravital microscopy, and each is optimized for its targeted organ. The mammary fat pad window 17 has been developed to study healthy and tumorigenic mammary tissue in mice 18 . The dorsal skinfold chamber is used to image the subcutaneous tissue, as well as tumor growth in the skin 19, 20 . The cranial window, created by replacing a portion of the mouse skull with a glass coverslip that is permanently secured to the skull with glue, is used to image the brain 21 . Other chronic windows developed for imaging the nervous system include a mouse spinal cord window 22 and a rat peripheral nerve window 23 , which transposes the sciatic nerve to surrounding muscle tissue, providing stable access to this nerve. Last, an abdominal imaging window has been developed to chronically image abdominal organs 24 . Our CLNW is comparable to these windows in concept. To image the inguinal lymph node using intravital microscopy as previously described in Jeong et al. 1 , we modified the chronic mammary fat pad window model. Similar to the mammary and abdominal imaging windows, the CLNW allows for coverslip replacement, giving access to the tissue (e.g., for cleaning or experimental manipulation) without having to adjust the surgical preparation. This capability allows better image acquisition over time. Similar to other window chambers, the CLNW uses titanium for its known biocompatibility and favorable strength-to-weight properties. The CLNW and its schematic design are shown in Figure 1 and Supplementary  Figures 1-3 , respectively.
Limitations
The CLNW implantation will impair leg movement in mice weighing less than ~25 grams (age 6-8 weeks). The procedure is considered major surgery, and therefore animals need time to recover before additional anesthesia is administered for imaging. We allow the animal to recover for 48 h after surgery before imaging begins, during which time we administer acetaminophen chronically in accordance with recommendations from the Massachusetts General Hospital (MGH) Institutional Animal Care and Use Committee (IACUC).
The inguinal lymph node undergoes minimal morphological, cellular and biochemical changes during the first 14 days after CLNW implantation, as described by Jeong et al. 1 . Briefly, local inflammation and vascular remodeling is microscopically absent in the physiologic lymph node post CLNW implantation, as shown by imaging and immunofluorescence staining. In addition, lymphotoxin-β receptor (LTbR) and tumor necrosis factor (TNF) expression remains low for 2 weeks postoperatively (see Supplementary Fig. 1d in Jeong et al. 1 ). A transient increase in interferon gamma (IFNγ) was noted 2 d postoperatively, but IFNγ levels returned to baseline shortly thereafter. Together, these data indicate that some transient regional inflammation due to the surgery is to be expected at day 2 postoperatively and is resolved by day 4. Thereafter, stable levels of inflammatory cytokines and little to no changes in lymph node architecture are to be expected. On the basis of longitudinal second-harmonic generation (SHG) imaging of collagen in the CLNW, fibrillar collagen content or organization does not change because of the presence of the CLNW. Further, we characterized the immune cell populations by flow cytometry data in Balb/c mice on days 2, 7 and 14 after CLNW implantation in comparison with mice without CLNW implantation (Supplementary Fig. 4 ). These data show no significant changes in the total CD45 + cell populations through day 7 (P > 0.05), although by day 14 there are differences in the number of CD45 + cells, as well as in many CD45 + subpopulations (Supplementary Fig. 4c ). After 14 d, in animals in which all subcutaneous fat covering the lymph node was removed, mild inflammation and gradual loss of perfusion in cortical blood vessels became apparent, and therefore it is not recommended to continue to image in these animals.
This preparation provides visual access predominantly to the lymph node cortical region. With sufficient practice, a surgical success rate of 100% is achievable and substantial movement of the lymph node over days can be prevented, although slight rotational changes cannot always be avoided. Therefore, we suggest using an imaging method that can acquire images in both the horizontal and vertical axes to ensure you will always be able to identify the same imaging region.
Experimental design
Any mice aged >8 weeks can be used. Murine tumor cell lines can be administered before imaging (Step 1) to generate spontaneous inguinal lymph node metastasis in various immune-competent mouse strains, if desired.
For optimal microscopy, the optical clarity of the CLNW is critical. The coverslip can be replaced when tissue exudate impairs image quality without altering the surgical preparation. This is accomplished based on the design of the titanium frame, in which the coverslip is secured through the use of a tension C-ring. When employing imaging modalities using water-immersion objectives, the coverslip should be sized using precise dimensions to prevent leakage of water. When mounted to an imaging stage, the titanium frame prevents respiratory movement during imaging, permitting high-resolution imaging in vivo. Step 4
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Step The titanium frame can cause skin damage on the ventral side; therefore, a layer of surgical tape wrapped around the side of the ventral titanium frame will prevent unnecessary harm to the animal and improve the experimental conditions (Fig. 2) . For longerterm experiments, the coverslip may cause superficial damage to the lymph node if the subcutaneous fat overlying the lymph node is removed; this will become apparent by the gradual loss of perfusion in cortical blood vessels starting after 14 d. Depending on the question to be answered, and keeping in mind the limitations of the imaging modality used, the direct exposure of the lymph node to the coverslip can be adjusted by altering the timing of when the subcutaneous fat is removed and the amount of fat removed. Complete removal of subcutaneous fat covering the lymph node will allow for at least 14 d of imaging, and all experiments described in this protocol were performed with complete removal of the subcutaneous fat covering the lymph node.
We have developed an imaging stage specifically designed for the CLNW to prevent (large) rotational changes, as well as respiratory movement ( Supplementary Figs. 5-10 ). Sequential imaging of the same location over multiple days is achieved at the macro scale by returning to the same position within the CLNW, as the lymph node will remain in place if the CLNW is implanted correctly. If needed, a small ink mark on the cover glass can be made to circumscribe the previous imaging area. At the micro scale, the same location can be found by tracking anatomical landmarks such as blood vessels and collagen structure (Fig. 3) .
This works well for frequent imaging sessions in tissue not undergoing large-scale remodeling.
In lymph nodes with extensive vascular remodeling, identifying collagen structure by SHG imaging or by the locations of larger unchanged blood vessels can help in imaging identical regions over time (Fig. 3) . In lymph nodes with extensive expansion (e.g., caused by experimental inflammation models or metastasis), the coverslip will keep the lymph node in its same general orientation with respect to the imaging window. This is important for lymph nodes undergoing large changes owing to inflammation, adaptive immune response or growth of metastatic cancer. With these scenarios, the ability to measure micro-level changes is less meaningful as compared with the ability to measure massive changes in cellular content and general architecture of the node. The CLNW allows for the kinetics of these processes to be monitored in a more efficient and controlled manner than could be achieved by looking collectively at cohorts of similarly treated animals at staggered time points.
Animals are not expected to have reduced vital signs or body weight. The researcher should be experienced with the surgery to obtain reproducible results. For experiments in which pharmacological treatments are included, animals with and without CLNW should be compared to examine possible overall health effects of the CLNW and analgesics. When examining effects using in vivo imaging, treated CLNW-implanted animals should be compared with nontreated CLNW-implanted animals. 
MaterIals

REAGENTS
 crItIcal All reagents and equipment can be substituted with appropriate alternatives from other manufacturers.
Mice: preferably aged 8-10 weeks or older and weighing at least 25 g. Strain and sex are dependent on the experiment. We have successfully used
• C3H mice, BALB/c mice, C57BL/6 mice, nude mice and mice from a mixed background. All mice were bred and kept in our animal facility ! cautIon All animal studies must be reviewed and approved by the relevant local IACUC and must conform to all relevant ethics regulations. We obtained institutional approval for this procedure from the MGH IACUC. Fig. 1; Supplementary Fig. 1 ) Custom-made titanium ring ( Fig. 1; Supplementary Fig. 2 ) Tension C-ring insert (McMaster, cat. no. 91580A146) M2x6 socket cap screws (McMaster, cat. no. 91290A013) REAGENT SETUP Anesthesia Mix ketamine and xylazine with sterile saline to obtain a concentration of 100 mg/ml for ketamine and 10 mg/ml for xylazine in a single dilution. The ketamine-xylazine mixture can be stored for up to 3 months at room temperature.
EQUIPMENT SETUP Surgical station
The surgery must be performed in an aseptic working environment. Therefore, we recommend performing surgery in a laminar flow hood with sterile equipment inside while practicing sterile surgical technique. Surgical kit preparation All items must be sterilized before surgery. The surgical tray, microdissection scissors, scissors, two Dumont no. 5 forceps, the needle holder and all CLNW components, including coverslips, should be sterilized. Animal housing All animals should be caged separately postoperatively. Food should be placed directly on the bedding and a cage discouraging climbing is preferred to prevent the animal getting stuck owing to the titanium chamber. Mouse well-being should be monitored per the relevant guidelines and regulations in place.
• preoperative preparations • tIMInG 10 min 3| Place the mouse on the scale to weigh it. Anesthetize the mouse using the ketamine-xylazine mixture (100 mg/10 mg per kg body weight). Maintain the body temperature at 37 °C throughout the procedure using a heating pad at 39 °C. Apply ophthalmic ointment to both eyes.
4|
Remove hair by shaving the area of the mouse bounded by the femoral region and the hypochondriac region, and the ventral and dorsal midlines (Fig. 2a) . Subsequently, apply hair removal cream. Remove the cream after 30-60 s with sterile water and cotton gauze to prevent chemical skin burn.
surgery • tIMInG 15 min 5| Pull a suture through the most posterior of the smaller holes of the CLNW frame. Place the suture above the subiliac lymph node 2 mm from the edge of the regio plicae genus, with the mouse in the supine position, and secure the CLNW in this position with a surgical knot (Fig. 2b,c, white arrow) . The lymph node location ( Fig. 2b-d , yellow asterisk) can be noninvasively determined by highlighting the lymph node through the skin with bright light from the dorsal side while looking at the ventral side. If the lymph node is not visible, use the nipple of the fourth mammary fat pad to approximate its position. Optimal positioning of this suture is important for centering the lymph node in the imaging window. The surgical preparation is depicted in Figure 2 .
6| Place two screws through the most lateral holes in the CLNW and secure them by tightening one nut each to the frame. Starting with the screw closest to the leg, pierce the skin directly above the screw using a scalpel or scissors and place the screw through the hole. Repeat for the second screw (Fig. 2c) .
? trouBlesHootInG 7| Wrap a layer of surgical tape around the side of the second CLNW frame to prevent unnecessary harm to the animal. Place the second CLNW frame on top of the other (Fig. 4) , with the skin in between. Cut away tape obstructing the titanium ring opening. Secure this CLNW with two additional nuts, this time only loosely tightening them (Fig. 2d) . ! cautIon Do not overtighten these nuts, as this will impede blood flow to the inguinal region and subiliac lymph node. Check the range of motion of the limb to ensure that the animal can move its limb. The positions of these nuts will be secured in Step 10.
8|
Remove the suture placed in the dorsal CLNW in Step 5 (Fig. 2b, white arrowhead) . Place two or three sutures through each of the holes on the ventral CLNW. Together with the CLNW, these sutures will keep the tissue in place for 14 d. Placing the sutures through one but not both CLNW frames makes it harder for the animal to remove the sutures. Placing these sutures through only the ventral CLNW frame specifically allows for microscopy using water-immersion objectives so that the water will remain in place.
9|
Place the mouse under the surgical bright-field microscope. Use microdissection scissors to open one layer of ventral skin ~6 mm in diameter (Fig. 2e) . If substantial bleeding occurs from the cutaneous blood vessels, use a cautery to stop the bleeding. Usually, the lymph node will be visible after opening the dermis. Any overlying subcutaneous fat can be removed using curved blunt 5.0 forceps.  crItIcal step If the lymph node is not directly visible, carefully explore the mammary fat pad using blunt dissection. Do not use a cautery in the vicinity of the lymph node, nor use forceps directly on the lymph node, as this will inflict irreversible damage.
? trouBlesHootInG
10|
Apply sterile saline to the wound area to prevent tissue dehydration. Place a glass coverslip into the CLNW groove, covering and protecting the lymph node, and secure the coverslip using a tension C-ring (Fig. 2f) . Use glue to secure the nuts applied loosely to the screws in Step 7 to prevent CLNW detachment. Monitor daily to make sure that the animal is fully ambulatory, with the CLNW in place, and that it shows no signs of edema caused by the CLNW. Wait 2 d before administering anesthesia for imaging or other experimental procedures.
? trouBlesHootInG Imaging tIMInG 15-90 min, beginning 48 h or more after clnW implantation 12| For all imaging procedures, check whether the imaging setup you are using is working correctly, as appropriate for the system being used and according to the manufacturer's guidelines. Then, anesthetize the mouse using a 100/10 mg ketamine-xylazine mixture per kg body weight or by using isoflurane.
13|
Position the mouse on an imaging stage (Figs. 5 and 6 ). For fluorescence-based angiography, inject 2,000,000 MW tetramethylrhodamine-dextran (or similar) intravenously.
14|
If using multiphoton imaging with a broadband femtosecond laser source (used as we described previously 13, 25 ), set the laser to ~60 mW on sample laser power at an 820-nm wavelength for tetramethylrhodamine detection before imaging.
15| Use the slowest acquisition time to get the best-quality images possible and do not digitally alter gain or offset. Perform xyz or xyzt (for video) imaging, with z (depth) ~20-100 µm. Images from Figure 3 were obtained using Olympus FluoView software with a 25× 1.05 numerical aperture (NA) water-immersion objective at 1× zoom, stack z ~50 µm, 512 × 512 pixels, and 16-bit. For signal detection, use a 610DF75 emission filter for tetramethylrhodamine (blood vessels), a 535DF43 filter for green (GFP cancer cells) and a 450DF100 filter for SHG imaging in front of the photomultiplier tubes. We use a motorized stage (Prior Scientific, model no. H101) combined with customized automation software (LabVIEW) to obtain mosaic images. Settings were similar for the supplementary videos (supplementary Videos 1 and 2); small differences are listed in their respective legends. ImageJ (National Institutes of Health (NIH)), or similar image analysis software, can be used to combine data acquired from different photomultiplier tubes. Images with data combined from different color channels can help co-localize different features in your experimental system. ? trouBlesHootInG
? trouBlesHootInG
Troubleshooting advice can be found in table 1. 
antIcIpateD results
For the first 14 d after surgery, clear, high-quality images are expected using the CLNW. The CLNW will also prevent movement artifacts during imaging and will not impede blood or lymph flow if implanted properly. For this purpose, the surface of the glass coverslip can be easily cleaned with ethanol before imaging, or the coverslip can be removed and replaced. As noted earlier, minimal morphological, cellular and biochemical changes are expected (see Supplementary Figs . 1d and 4 in Jeong et al. 1 ) and successive surgeries are not required for exposing the imaging window in the CLNW. Examples of imaging results after CLNW implantation are shown in Figure 3 . The lymph node and surrounding vasculature can be imaged by optical coherence tomography (Fig. 3a) . Metastatic Dendra2-expressing 4T1 breast cancer (green) in the inguinal lymph node (Fig. 3b,c) can be monitored longitudinally. Blood vessels were used to repeatedly find the region of interest in the lymph node, allowing the imaging to be centered on the growing metastatic lesion. Blood vessels can be identified by intravenous injection of fluorescently labeled dextran.
To generate metastatic lymph nodes, squamous cell carcinomas or melanomas can be injected into the thigh subcutis or breast tumor cells can be injected into the fourth mammary fat pad of the mouse; these will subsequently metastasize to the inguinal lymph node. Lymphangiography can be used to confirm whether tumors drain to the inguinal lymph node 1, 26 . At the early stages of lymph node metastasis-~7 days post tumor implantation of the 4T1 breast cancer cell line-tumor cells can be visualized in the subcapsular sinus of the lymph node. At later time points, these cells invade the parenchyma, moving toward blood vessels 1 . The timing of CLNW implantation can be tailored to the research question and the metastatic behavior of the tumor cell line. Tumor chunk implantation of the primary tumor can be considered to avoid direct spread of tumor cells into the inguinal lymph node from the initial injection. To study immune cell behavior in metastatic lymph nodes, fluorescently labeled immune cells can be adoptively transferred to a tumor-bearing mouse and subsequently imaged in the tumor-draining lymph node using the CLNW.
In addition to monitoring the progression of tumor growth in the lymph node over days, it is possible to perform shortterm time-lapse intravital imaging using the CLNW to analyze tumor cell interaction with immune cells and other lymph node stromal cells, as has also been accomplished using prior models 3, 7, 8 . supplementary Video 1 shows a maximum-intensity project of a 3D lymph node tissue acquired by time-lapse multiphoton microscopy in LysM-GFP transgenic mice. Lymph node neutrophil and monocyte movement (green) in blood vessels (red) and lymph node tissue can be observed. In supplementary Video 2, time-lapse microscopy was performed at a higher resolution for a high-endothelial vessel in the lymph node that shows GFP-positive cells flowing, rolling and extravasating. 
